Core Insights - The article discusses the emerging trend of real-world asset (RWA) tokenization in the crypto space, highlighting its potential for faster and cheaper settlement of traditional financial instruments on blockchains [1] - It emphasizes two cryptocurrencies, Solana and XRP, as key players in this megatrend, each with distinct approaches to asset tokenization [2] Group 1: Solana - Solana is characterized by its high throughput and low transaction fees, enabling over 1,000 transactions per second at minimal costs, which is beneficial for tokenized stocks [3][4] - The total value of tokenized assets on Solana has surged to approximately $553 million, reflecting a growth of over 218% this year, significantly outpacing the overall sector growth [5] - Projections from Boston Consulting Group suggest that tokenized real-world assets could reach $16 trillion by 2030, which would increase demand for Solana as validators lock up the coin for staking [8] Group 2: XRP - The XRP Ledger focuses on compliance features that appeal to banks, such as account freezing and KYC tools, making it attractive for issuers of regulated debt and payment instruments [11] - XRP has seen its tokenized assets grow to around $133 million, with a significant portion being institutional debt, including a $75.2 million platform for tokenized U.S. Treasury bills [12][13] - The design of the XRP Ledger aligns with regulatory requirements, providing a competitive advantage as institutional players enter the crypto market [14][15]

Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig") and Streamex Exchange Corporation ("Streamex"), collectively referred to as the combined company, today announced successful completion of the previously disclosed share exchange transaction and executive leadership changes, forming a company specializing in the tokenization of real-world assets, with a focus on bringing commodities on-chain. Key Highlights of the Transaction: Streamex Ex ...

Core Viewpoint - BioSig Technologies, Inc. has signed a definitive share exchange agreement with Streamex Exchange Corporation, marking a significant milestone in the business combination aimed at enhancing the tokenization of real-world assets, particularly in the commodities sector [1][2]. Company Overview - BioSig Technologies is a medical technology company focused on innovative solutions, while Streamex specializes in the tokenization of real-world assets, particularly commodities [1][7]. - The combined entity will be led by Henry McPhie, Co-Founder and CEO of Streamex, with Anthony Amato transitioning to a board role [5]. Transaction Highlights - The share exchange will result in Streamex becoming a wholly owned subsidiary of BioSig, with existing Streamex shareholders entitled to receive 75% of the fully diluted BioSig common stock post-transaction [5][12]. - The transaction is expected to unlock new value in the US$142.85 trillion global commodity market by bringing commodities on-chain through secure tokenization solutions [5][13]. Strategic Additions - Notable strategic advisors have joined the combined company, including Frank Giustra, Mathew August, and Mitchell Williams, bringing extensive experience in commodities and capital markets [6]. Market Positioning - Streamex aims to revolutionize commodity finance by bridging traditional finance with the digital economy, enhancing liquidity, accessibility, and efficiency through innovative financial technologies and blockchain [8].